Concepedia

Elisa Zanini

EZ

Statistics

Publications

6

Citations

365

H-Index

6

Active since

2012

Affiliations

Ovarian Cancer Action(Current)

Imperial College London

AstraZeneca (United Kingdom)

Elisa Zanini is an author at Ovarian Cancer Action specializing in molecular oncology, oncology, and ovarian cancer.

ORCID

Publications per year

2012–2019

6

Publications

6

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer

Danilo Swann Matassa, Maria Rosaria Amoroso, Haonan Lu et al. · Cell Death and Differentiation · 2016 · 201 citations · Full text

, , +15

The OPCML Tumor Suppressor Functions as a Cell Surface Repressor–Adaptor, Negatively Regulating Receptor Tyrosine Kinases in Epithelial Ovarian Cancer

Arthur B. McKie, Sebastian Vaughan, Elisa Zanini et al. · Cancer Discovery · 2012 · 51 citations · Full text

, , +17

WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response

Szymon Janczar, Jaya Nautiyal, Yi Xiao et al. · Cell Death and Disease · 2017 · 35 citations · Full text

, , +17

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer

Jane Antony, Elisa Zanini, Zoe Kelly et al. · EMBO Reports · 2018 · 35 citations · Full text

, , +12

The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer

Elisa Zanini, Louay Louis, Jane Antony et al. · Molecular Cancer Therapeutics · 2017 · 27 citations · Full text

, , +17

1–5 of 6